Worldwide Dengue Vaccine Industry to 2025 – Key Drivers, Challenges and Trends – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Dengue Vaccine Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The publisher has been monitoring the dengue vaccine market and it is poised to grow by $132.90 million during 2021-2025, progressing at a CAGR of about 18% during the forecast period.

This report on the dengue vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rapid growth in disease prevalence and ineffective dengue control measures.

The dengue vaccine market analysis includes the end-user segment and geographic landscape. This study identifies the initiatives for dengue vaccine research and dengue immunization programs as one of the prime reasons driving the dengue vaccine market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

Companies Mentioned

• BioNet-Asia Co. Ltd.
• Chula VRC
• Codagenix Inc.
• GeneOne Life Science Inc.
• Imutex Ltd.
• KM Biologics Co. Ltd.
• Medigen Biotechnology Corp.
• Najit Technologies Inc.
• Sanofi SA
• Emergex Vaccines Holding Ltd.

This report on dengue vaccine market covers the following areas:

• Dengue vaccine market sizing
• Dengue vaccine market forecast
• Dengue vaccine market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The publisher’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Key Topics Covered:

1. Executive Summary

• Market overview

2. Market Landscape

• Market ecosystem
• Value chain analysis

3. Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 – 2025

4. Five Forces Analysis

• Five Forces Analysis
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

5. Market Segmentation by End-user

• Market segments
• Comparison by End-user
• Government institutions – Market size and forecast 2020-2025
• Hospitals – Market size and forecast 2020-2025
• NGOs – Market size and forecast 2020-2025
• Market opportunity by End-user

6. Customer Landscape

7. Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2020-2025
• Asia – Market size and forecast 2020-2025
• Europe – Market size and forecast 2020-2025
• ROW – Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

8. Vendor Landscape

• Vendor landscape
• Competitive Scenario
• Landscape disruption

9. Vendor Analysis

• Vendors covered
• Market positioning of vendors
• BioNet-Asia Co. Ltd.
• Chula VRC
• Codagenix Inc.
• Emergex Vaccines Holding Ltd.
• GeneOne Life Science Inc.
• Imutex Ltd.
• KM Biologics Co. Ltd.
• Medigen Biotechnology Corp.
• Najit Technologies Inc.
• Sanofi SA

10. Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/5hvt37

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900